226 related articles for article (PubMed ID: 12508833)
1. Neuroreceptor imaging in psychiatric disorders.
Frankle WG; Laruelle M
Ann Nucl Med; 2002 Nov; 16(7):437-46. PubMed ID: 12508833
[TBL] [Abstract][Full Text] [Related]
2. Receptor and transporter imaging studies in schizophrenia, depression, bulimia and Tourette's disorder--implications for psychopharmacology.
Kasper S; Tauscher J; Willeit M; Stamenkovic M; Neumeister A; Küfferle B; Barnas C; Stastny J; Praschak-Rieder N; Pezawas L; de Zwaan M; Quiner S; Pirker W; Asenbaum S; Podreka I; Brücke T
World J Biol Psychiatry; 2002 Jul; 3(3):133-46. PubMed ID: 12478878
[TBL] [Abstract][Full Text] [Related]
3. Neurochemical imaging in schizophrenia.
Urban N; Abi-Dargham A
Curr Top Behav Neurosci; 2010; 4():215-42. PubMed ID: 21312402
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography and single photon emission CT molecular imaging in schizophrenia.
Erritzoe D; Talbot P; Frankle WG; Abi-Dargham A
Neuroimaging Clin N Am; 2003 Nov; 13(4):817-32. PubMed ID: 15024964
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of schizophrenia: Neurochemical findings in a heterogeneous and evolving disorder.
Cumming P; Abi-Dargham A; Gründer G
Behav Brain Res; 2021 Feb; 398():113004. PubMed ID: 33197459
[TBL] [Abstract][Full Text] [Related]
6. Applications of positron emission tomography in psychiatry.
Parsey RV; Mann JJ
Semin Nucl Med; 2003 Apr; 33(2):129-35. PubMed ID: 12756645
[TBL] [Abstract][Full Text] [Related]
7. Dopamine- and serotonin-receptors in schizophrenia: results of imaging-studies and implications for pharmacotherapy in schizophrenia.
Kasper S; Tauscher J; Küfferle B; Barnas C; Pezawas L; Quiner S
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 4():83-9. PubMed ID: 10654113
[TBL] [Abstract][Full Text] [Related]
8. A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy.
Kapur S; Zipursky R; Jones C; Shammi CS; Remington G; Seeman P
Arch Gen Psychiatry; 2000 Jun; 57(6):553-9. PubMed ID: 10839333
[TBL] [Abstract][Full Text] [Related]
9. Imaging of receptors in clinical neurosciences.
Korf J
Acta Neurol Belg; 1997 Sep; 97(3):200-5. PubMed ID: 9345594
[TBL] [Abstract][Full Text] [Related]
10. In vivo neuropharmacology of schizophrenia.
Bigliani V; Pilowsky LS
Br J Psychiatry Suppl; 1999; (38):23-33. PubMed ID: 10884897
[No Abstract] [Full Text] [Related]
11. Neuroreceptor imaging of stress and mood disorders.
Kennedy SE; Zubieta JK
CNS Spectr; 2004 Apr; 9(4):292-301. PubMed ID: 15048054
[TBL] [Abstract][Full Text] [Related]
12. The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.
Talbot PS; Laruelle M
Eur Neuropsychopharmacol; 2002 Dec; 12(6):503-11. PubMed ID: 12468013
[TBL] [Abstract][Full Text] [Related]
13. [Functional imaging in mental disorders].
Borbély K
Orv Hetil; 2004 Feb; 145(6):277-89. PubMed ID: 15038321
[TBL] [Abstract][Full Text] [Related]
14. A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone.
Mamo D; Kapur S; Shammi CM; Papatheodorou G; Mann S; Therrien F; Remington G
Am J Psychiatry; 2004 May; 161(5):818-25. PubMed ID: 15121646
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical brain imaging investigations of schizophrenia.
Soares JC; Innis RB
Biol Psychiatry; 1999 Sep; 46(5):600-15. PubMed ID: 10472414
[TBL] [Abstract][Full Text] [Related]
16. Imaging as tool to investigate psychoses and antipsychotics.
Booij J; van Amelsvoort T
Handb Exp Pharmacol; 2012; (212):299-337. PubMed ID: 23129337
[TBL] [Abstract][Full Text] [Related]
17. Applications of neuroreceptor imaging to psychiatry research.
Smith GS; Koppel J; Goldberg S
Psychopharmacol Bull; 2003; 37(4):26-65. PubMed ID: 15131516
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
[TBL] [Abstract][Full Text] [Related]
19. [Current concepts of the effects of neuroleptics].
Kostowski W; Płaźnik A
Psychiatr Pol; 1990; 24(5):28-37. PubMed ID: 1983397
[No Abstract] [Full Text] [Related]
20. Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders.
Royse SK; Lopresti BJ; Mathis CA; Tollefson S; Narendran R
J Neurochem; 2023 Feb; 164(3):401-443. PubMed ID: 35716057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
